Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy.
Koppikar P, Bhagwat N, Kilpivaara O, Manshouri T, Adli M, Hricik T, Liu F, Saunders LM, Mullally A, Abdel-Wahab O, Leung L, Weinstein A, Marubayashi S, Goel A, Gönen M, Estrov Z, Ebert BL, Chiosis G, Nimer SD, Bernstein BE, Verstovsek S, Levine RL.
Koppikar P, et al. Among authors: liu f.
Nature. 2012 Sep 6;489(7414):155-9. doi: 10.1038/nature11303.
Nature. 2012.
PMID: 22820254
Free PMC article.